ClinicalTrials.Veeva

Menu

ADAMTS,Proteoglycan and Oxidant / Antioxidant Enzyme Levels of Placenta Previa Totalis (Accreta, Increta, Percreta).

Z

Zekai Tahir Burak Women's Health Research and Education Hospital

Status

Unknown

Conditions

Placenta Previa

Study type

Observational

Funder types

Other

Identifiers

NCT02270593
prospective study-2

Details and patient eligibility

About

Placenta previa totalis (accreta, increta, percreta); ADAMTS and proteoglycans and the oxidant / antioxidant enzyme levels.

Full description

Placenta previa totalis (accreta, increta, percreta) of pregnant women in the maternal serum, fetal membranes (placenta) and hysterectomy of women with myometrial strips measured the ADAMTS and proteoglycans expression levels, and the oxidant / antioxidant enzyme levels.

Enrollment

30 estimated patients

Sex

Female

Ages

25 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • pregnant women diagnosed with placenta previa by obstetric ultrasound and doppler

Exclusion criteria

  • Pregnant women with comorbid diseases other than previa totalis .

Trial design

30 participants in 1 patient group

Placenta previa
Description:
first; maternal serum, fetal membranes (placenta) and maternal myometrial samples will be investigated for ADAMTS, Proteoglycans and oxidative/antioxidative enzyme status levels in patients with placental invasion anomalies Placenta Previa totalis by ELISA, western blot, immunohystochemistry and PCR (polymerase chain reaction).

Trial contacts and locations

1

Loading...

Central trial contact

sibel özler, md

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems